… it will be expanding its immunology capabilities by acquiring Capstan Therapeutics … to reset the immune system.” Immunology is a key focus area … degraders for multiple targets across immunology and oncology, with the deal …

… s Max Cooper Prize in Immunology.  Reviewing a pool of … contributions to the field of immunology at the fundamental and … leaders in the field of immunology, and their contributions represent … launching the course of modern immunology.  The awardees will be …

… ’s world-leading expertise in immunology research, clinical development, and its …

… company specializing in developing AI-Immunology™ powered vaccines, announces several key … value from its proprietary AI-Immunology™ platform and pipeline. Christian Kanstrup … Evaxion and its groundbreaking AI-Immunology™ platform and vaccine pipeline, …

… from cancer and into the immunology category, tapping into the understanding … a big player in the immunology and inflammation (I&I …

… chronic disease typically requires redosing. Immunology and inflammation is already a … expanding their labels to multiple immunology indications. Capstan brings a new … strategic effort to strengthen its immunology franchise with novel, disease-modifying …

The new acquisition, worth up to $2.1 billion, gives AbbVie rights to a potential first-in-class drug for B cell-mediated autoimmune diseases. AbbVie has agreed to acquire Capstan Therapeutics, Inc., of which the deal includes rights to a potential first- …

… ’s already strong position in immunology, building on the success of …

… ;s world-leading expertise in immunology research, clinical development, and its … several key therapeutic areas including immunology, oncology, neuroscience and eye care … -to-transforming-patient-care-in-immunology-302494390.html SOURCE AbbVie

… Journal of Allergy and Clinical Immunology: In Practice in May 2025 …